The OctariusRx 2026 Medication Calculations Quiz helps healthcare professionals improve dosing accuracy, reduce errors, and strengthen patient safety practices.
Tag: ASC compliance
Celebrating National Nurses Week 2026: Honoring the Heart of Healthcare
OctariusRx celebrates National Nurses Week 2026 by honoring nurses in hospitals, clinics, ASCs, and long-term care for their dedication to patient safety and quality care.
The Benefits of Using a Consultant Pharmacist at an Ambulatory Surgery Center
Discover how a consultant pharmacist can enhance safety, compliance, and efficiency in your ambulatory surgery center with expert guidance from OctariusRx.
Patient Safety Awareness Week 2026: Strengthening Safety Through Pharmacy Collaboration
During Patient Safety Awareness Week 2026, OctariusRx highlights pharmacist-led strategies—audits, training, and interdisciplinary collaboration—that help ambulatory surgery centers reduce medication risk and improve patient outcomes.
Malignant Hyperthermia (MH) Awareness & Training Month — March
March is Malignant Hyperthermia Awareness & Training Month—a vital reminder for ASCs to review protocols, train staff, and ensure readiness to manage MH emergencies effectively.
The 2026 Controlled Substances Assessment Quiz
The 2026 Controlled Substances Assessment Quiz from OctariusRx — updated for current DEA guidance. Use this annual competency tool to assess staff, reduce diversion risk, and document compliance for ASCs and healthcare facilities.
What’s Driving Drug Shortages?
Drug shortages are a growing challenge in healthcare. Learn what’s driving them, how they impact ASCs, and steps your facility can take to stay prepared.
How a Consultant Pharmacist Helps Prevent Drug Diversion in Ambulatory Surgery Centers
Consultant pharmacists play a vital role in helping Ambulatory Surgery Centers prevent drug diversion. Learn how OctariusRx supports compliance, safety, and oversight.
What’s New in the 2025 MHAUS OR Poster for ASCs — What Ambulatory Surgery Centers Need to Know
An overview of the 2025 MHAUS OR poster updates and what they mean for ASC malignant hyperthermia preparedness, compliance, and patient safety.
2025 FDA Updates on Tranexamic Acid: What Ambulatory Surgery Centers Need to Know
The FDA’s 2025 update on tranexamic acid strengthens safety warnings for IV-only use and mandates new labeling. Learn how OctariusRx helps ASCs stay compliant and enhance medication safety.









